ylliX - Online Advertising Network
Company Ticker News

Regeneron’s antibody drug reduces risk of death in some Covid patients

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

CNBC’s Meg Tirrell joins ‘The News with Shepard Smith’ to discuss the Regeneron antibody drug, which reduces the risk of death by 20% in some Covid patients. The drug is a combination of two antibodies which combat the virus,

...read full article on CNBC Television

ylliX - Online Advertising Network